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Interferon regulatory factors play an important role in the transcriptional regulation of immunity. In this issue
of Immunity, Kumamoto et al. (2013) and Gao et al. (2013) identify an Irf4-dependent migratory dendritic cell
subset required for T helper 2 cell polarization following cutaneous challenge.The T helper 2 (Th2) cell differentiation
pathway has historically been referred
to as the default pathway of CD4+ T cell
differentiation because in model systems
where Th1 cell-mediated immunity is
blocked by means of deletion of inter-
feron-g (IFN-g) or T-bet transcription
factor expression, immunity appears
to ‘‘default’’ to a Th2 cell response. In
contrast, loss of individual factors such
as interleukin-4 (IL-4) or thymic stromal
lymphopoietin (TSLP), although important
in specific Th2 cell differentiation models,
does not appear to lead to universal
loss of Th2 cell-mediated immunity
(Kool et al., 2012). Furthermore, Th2 cell
responses in skin tissue occur under
conditions of ‘‘sterile stress’’ by means
of the lymphoid stress surveillance
response (Strid et al., 2011). The special-
ized role of CD8a+ lymphoid-resident
dendritic cells (DCs) and other ontogeni-
cally related DCs such as the CD103+
migratory DCs has in recent years
received considerable attention because
of their crucial role in priming of cytotoxic
T lymphocyte (CTL) responses. Consider-
able progress has also been made in
the understanding of the respective
contributions of Langerhans cells and
Langerin+ dermal DCs in the priming of
Th17 and Th1 cell-mediated immunity
in the skin (Igya´rto´ et al., 2011). Compara-
tively, there has been a poorer under-
standing of the role of different DC
subsets in the generation of Th2 cell
responses. However, depletion models
have now demonstrated that CD11c+
DCs (Kool et al., 2012) but not Langerin+
(CD103+) DCs are required for priming
Th2 cell responses (Igya´rto´ et al., 2011).It is therefore reasonable to predict that
a population of CD11c+ Langerin DCs
are responsible for Th2 cell polarization,
and this prediction is supported by work
published this year in which house dust-
mite-sensitized CD11b+ lung DCs are re-
ported to be able to elicit a Th2 cell
response when adoptively transferred to
a secondary host (Plantinga et al., 2013).
Until now, a more complete characteriza-
tion of the DC subsets required for prim-
ing Th2 cell-mediated immunity and their
transcriptional programming in vivo has
been lacking.
CD11c+ conventional DCs are generally
subdivided on the basis of expression
of CD11b or CD8a in the lymph node
and CD11b or CD103 in the dermis. The
CD11b+ subsets can also be identified
by expression of CD301b, and enhanced
programmed death ligand-2 (PD-L2)
expression, although PD-L2 expression
can also be influenced by the activation
state of the cells. Under inflammatory
conditions, CD11b+ subsets of DCs also
include a population of monocyte-derived
cells, which might also express PD-L2
and CD301b (Gao et al., 2013). In this
issue of Immunity, two complementary
studies explore the role of specific DC
subsets in Th2 cell-mediated responses.
Kumamoto et al. (2013) base their study
on a system of forced expression of the
high-affinity diphtheria toxin (DT) receptor
under the Mgl2 promoter and deplete
CD301b+ cells by administration of DT
(Kumamoto et al., 2013), while Gao et al.
(2013) targeted deletion of interferon
regulatory factor 4 (Irf4) specifically in
CD11c-expressing cells by means of
the Cre-loxP system (Gao et al., 2013).Immunity 39Genetic deletion of Irf4 in DCs led to the
absence of PD-L2hi CD301b+ (CD8a)
migratory DCs from the skin-draining
lymph nodes of transgenic mice but not
from the skin itself. Th2 cell-mediated
responses were blunted in these ‘‘DC-
Irf4-deficient mice’’ with a dramatic
reduction in IL-4, IL-5, and IL-13 pro-
duction and loss of antigen-specific
immunoglobulin G1 (IgG1) and total IgE
in response to immunization with the
protease adjuvant papain and a similar
loss of Th2 cell-mediated responses after
subcutaneous helminth infection (Gao
et al., 2013). Depletion of CD301b+ DCs
with DT led to the loss of a similar popu-
lation of CD301b+ CD8a DCs in the
skin-draining lymph node and additionally
to depletion of their tissue-resident coun-
terparts in the dermis and unexpectedly
to loss of Langerhans cells. After DT injec-
tion, antigen uptake in the dermis and
presentation in the draining lymph node
was markedly reduced in response to
papain or alum, but not CpG. CD301b+
dermal dendritic cells are therefore re-
quired for CD4+ T cell accumulation and
IL-4 production specifically in response
to Th2 cell promoting stimuli (Kumamoto
et al., 2013). Taken together, the two
papers demonstrate the importance of
CD301b+ DC in Th2 cell priming and
the essential role played by IRF4 in these
cells (Figure 1).
DC-Irf4-deficient mice have now been
described in several publications and
are found to lack certain populations
of CD11b+ CD8a DC from the lamina
propria, the lung, and from tissue-draining
lymph nodes (Schlitzer et al., 2013;
Persson et al., 2013; Gao et al., 2013)., October 17, 2013 ª2013 Elsevier Inc. 625
Figure 1. DC-T Cell Interactions in the Generation of Th2 Cell-
Mediated Immunity
CD11b+ CD301b+ PD-L2hi DCs (left) under transcriptional control of the IRF4
transcription factor are able to direct Th2 cell responses. DCs pick up antigen
and can be activated either directly or indirectly by allergens, helminthes, or
other toxins. A responding naive T cell (right) must be stimulated throughmajor
histocompatibility complex (MHC) and costimulatory molecules to become
activated and requires additional signals to become polarized. Th2 cell-
inducing DC signals may include OX40L, CD40, Jagged, and IL-6. Basophils
and epithelial cells might also be required to provide Il-4, TSLP, or other
factors. T cells receiving these signals in the absence of IL-12 undergo Th2
cell differentiation under the transcriptional control of GATA-3, STAT5, and
STAT6. Th2 cells produce IL-4, IL-5, and Il-13—the effector molecules that
are important for their functions including eosinophil recruitment, B cell
help, and antibody class switching.
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inability to effectively mount
either Th17 cell-mediated
responses in the gut and
lung or Th2 cell-mediated re-
sponses in the skin. Th1 cell-
mediated responses on the
other hand are preserved.
Priming of Th2 and Th17 cell
responses, but not Th1 cell
responses, has previously
been shown to be dependent
on DC expression of c-Kit
and downstream produc-
tion of IL-6 (Krishnamoorthy
et al., 2008). Similarly Irf4-
deficient DC provide mark-
edly reduced levels of IL-6
in response to LPS and
CD40L stimulation in the gut
concomitant with the loss
of Th17 cell-mediated re-
sponses, suggesting that IL-
6 production is one possible
mechanism by which DC
IRF4 expression might influ-
ence Th cell skewing (Pers-
son et al., 2013), although itis unclear that IL-6 is a requirement for
Th2 polarization.
IRF4 is known to regulate transcription
of key cytokines involved in immune
responses. In B cells, IRF4 binds in coop-
eration with PU.1 or BATF to Ets or AP-1
motifs to control the transcription of
genes essential for the function of B cells
including the immunoglobulin light chains.
In T cells, IRF4 binds to motifs adjacent
to AP-1 motifs and seems to cooperate
with BATF and Jun family proteins to
regulate transcription of IL-21 induced
genes including IL-10 (Murphy, 2013).
The transcriptional targets of IRF4 in DC
are not well understood; it is reported
that IRF4-dependent PD-L2hi DCs ex-
press high levels of BATF3, a known
partner of IRF4, suggesting that these
proteins together might be important for
allowing DC to polarize Th2 cell-mediated
responses (Gao et al., 2013). However,
BATF3-deficient mice show no deficiency
in Th2 cell responses, but in contrast
lack CD8a+ DC and have impaired CTL
and Th1 cell-mediated responses (Mur-
phy, 2013). IRF4 deficiency has previously
been shown to inhibit the migration of
cutaneous DC to the draining lymph
nodes (Murphy, 2013), and this might
explain why CD11b+ DCs are present in626 Immunity 39, October 17, 2013 ª2013 Elthe dermis of DC-Irf4-deficient mice but
absent in the draining lymph node. The
consequence of reduced accumulation
of antigen-bearing DCs in the lymph
nodemight be suboptimal priming, which,
although sufficient to activate CD4+
T cells, is unable to polarize Th2 or Th17
cell responses. The discovery of factors
such as IRF4 that control the transcrip-
tional programming of specific subsets
of DCs is likely to lead to more accurate
definitions of developmentally related
cells; however, at present the mecha-
nisms by which they regulate DCs are
poorly understood. It will be particularly
important to more clearly elucidate
whether IRF4 directly regulates the
expression of genes that control T helper
cell polarization, such as cytokines
and surface receptors, or whether IRF4
is required for the generation, survival,
and migration of CD301b+ DCs, which
are otherwise programmed to influence
T helper cell polarization.
Because DCs are central to the polari-
zation and magnitude of immune re-
sponses, they are an attractive target for
in vivo manipulation of immunity. A
greater understanding of the speciali-
zation of DCs brings us a step closer
to realizing this goal. Attempts to alignsevier Inc.murine and human subsets
might aid translation into the
human setting, and it has
been reported that human
CD1c+ DCs show transcrip-
tional similarities with CD11b+
mouse DCs, including ex-
pression of IRF4. These DCs
are also able to produce IL-
23, suggesting that they might
influence Th17 cell responses
(Schlitzer et al., 2013). Howev-
er, there is not always a per-
fect fit between mouse and
human data. In human skin,
for instance, the major
CD141-expressing subset of
DCs makes up around 20%
of dermal DC but has no clear
counterpart in mice (Chu et al.,
2012). The contribution of
CD141+ and CD1c+ dermal
DC subsets to the polarization
of Th2 cell responses in hu-
mans therefore still requires
some dissection.
These studies add to the
body of evidence suggestingthat conventional DCs may be split into
two categories with respect to T cell prim-
ing. CD8a+ lymphoid DCs and Langerin+
migratory DCs are generally responsible
for cytotoxic CD8+ T cell responses and
the related Th1 cell-mediated response
in CD4+ T cells, whereas CD11b+ DC
subsets are responsible for skewing
either Th2 or Th17 cell responses. This
delineation might prove to be somewhat
tissue dependent, for instance in the
skin where Langerhans cells are also
implicated as major players in Th17 cell
differentiation, but serves as a useful
hypothesis for further investigation. Inter-
estingly, DCs alone are not necessarily
sufficient for the response, confirming
the potentially important role of other
cell types such as epithelial cells and
basophils in the development of Th2
cell-mediated immunity (Kool et al.,
2012). The two studies presented herein
do not dissect the requirement for
inflammatory CD11b+ DCs from conven-
tional CD11b+ DCs in Th2 cell-mediated
immunity, although it has previously
been shown in the lung that CD11b+
conventional DCs as opposed to mono-
cyte-derived cells are responsible for
Th2 cell development (Persson et al.,
2013). The presented papers set a
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Previewstheoretical paradigm that CD301b+ DCs
under the transcriptional control of IRF4
are required for the development of Th2
cell-mediated responses in vivo. Further
studies will be required to demonstrate
the practical result of the loss of DC-
Irf4 on Th2 cell-driven atopic dermatitis,
allergy, or the clearance of pathogens.
A deeper understanding of the function
and key partners of IRF4 in DCs will be
required in order to fully elucidate their
role in skewing Th2 versus Th17 cell-
mediated immunity. In the meantime
Gao et al. (2013) and Kumamoto et al.
(2013) have extended our understanding
of the DC subsets which ‘‘help 2’’ polarize
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Despite the discovery of the cytokine over 20 years ago, the relevant biological sources of interleukin-9 (IL-9)
have remained amystery. In this issue of Immunity, Licona-Limo´n et al. (2013) use a newly generated reporter
mouse to demonstrate a role for IL-9-secreting T cells in helminthic parasite immunity.Interleukin-9 (IL-9) was initially identified
on the basis of its ability to promote
T cell and mast cell growth (reviewed in
Goswami and Kaplan, 2011). Consistent
with the association between IL-9 and
type 2 immune responses, IL-9 promotes
allergic inflammation and immunity to hel-
minthic parasites. However, the relevant
sources of IL-9 during immune responses
are still incompletely defined, at least
partly because of a lack of genetic tools
for tracking IL-9-expressing cells. Re-
ports have documented IL-9 production
frommast cells and several T cell subsets,
including T helper 2 (Th2), Th17, and reg-
ulatory T cells, as among the potential
sources. The most potent producers of
IL-9 are innate lymphoid cells (ILCs) and
Th9 cells, which are derived in vitro in
the presence of the cytokines transform-
ing growth factor b (TGF-b) and IL-4
(Kaplan, 2013; Wilhelm et al., 2011) (Fig-ure 1). IL-9-producing ILCs are observed
in protease-induced allergic airway
inflammation and most likely contribute
to the proallergic milieu. Th9 cells are
also capable of promoting allergic inflam-
mation in several models. As of yet, no
comprehensive studies have examined
the source of IL-9 during helminthic para-
site infection. In this issue of Immunity,
Licona-Limo´n et al. (2013) describe the
generation of new IL-9-deficient and IL-9
reporter mice that make an important
contribution to our understanding of the
sources of IL-9 during the development
of immunity to Nippostrongylus brasilien-
sis, as well as the IL-9 target cells that
might be important for parasite clearance.
Helminthic parasite clearance depends
upon the development of Th2-cell-regu-
lated immune responses (Urban et al.,
1998), although it is understood that
many of the cytokines and transcriptionfactors that promote Th2 cell develop-
ment are also required for Th9 cell differ-
entiation. The requirement for IL-9 in
parasite immunity is less clear. Perhaps
owing to redundancy in function among
Th2-cell-type cytokines and IL-9, IL-9-
deficient mice on a mixed genetic back-
ground were able to clear N. brasiliensis
infection, although transgenic or exoge-
nous IL-9 clearly enhanced immunity to
additional parasites (reviewed in Gos-
wami and Kaplan, 2011). The reason for
differences among these models is un-
clear but suggests that the role of IL-9 in
parasite immunity is more complex and
might vary with pathogen, genetic back-
ground of the host, or other experimental
variables.
In this issue of Immunity, Licona-Limo´n
et al. generated Il9/ mice on a BALB/c
genetic background and a novel IL-9 re-
porter mouse by placing an IRES-EGFP, October 17, 2013 ª2013 Elsevier Inc. 627
